Cargando…

Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998

The International Cooperative Biodiversity Groups (ICBG) Program based at the University of Illinois at Chicago (UIC) is a program aimed to address the interdependent issues of inventory and conservation of biodiversity, drug discovery and sustained economic growth in both developing and developed c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong-Jie, Li, Wan-Fei, Fong, Harry H. S., Soejarto, Djaja Doel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273581/
https://www.ncbi.nlm.nih.gov/pubmed/27809237
http://dx.doi.org/10.3390/molecules21111448
_version_ 1783377418915938304
author Zhang, Hong-Jie
Li, Wan-Fei
Fong, Harry H. S.
Soejarto, Djaja Doel
author_facet Zhang, Hong-Jie
Li, Wan-Fei
Fong, Harry H. S.
Soejarto, Djaja Doel
author_sort Zhang, Hong-Jie
collection PubMed
description The International Cooperative Biodiversity Groups (ICBG) Program based at the University of Illinois at Chicago (UIC) is a program aimed to address the interdependent issues of inventory and conservation of biodiversity, drug discovery and sustained economic growth in both developing and developed countries. It is an interdisciplinary program involving the extensive synergies and collaborative efforts of botanists, chemists and biologists in the countries of Vietnam, Laos and the USA. The UIC-ICBG drug discovery efforts over the past 18 years have resulted in the collection of a cumulative total of more than 5500 plant samples (representing more than 2000 species), that were evaluated for their potential biological effects against cancer, HIV, bird flu, tuberculosis and malaria. The bioassay-guided fractionation and separation of the bioactive plant leads resulted in the isolation of approximately 300 compounds of varying degrees of structural complexity and/or biological activity. The present paper summarizes the significant drug discovery achievements made by the UIC-ICBG team of multidisciplinary collaborators in the project over the period of 1998–2012 and the projects carried on in the subsequent years by involving the researchers in Hong Kong.
format Online
Article
Text
id pubmed-6273581
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62735812018-12-28 Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998 Zhang, Hong-Jie Li, Wan-Fei Fong, Harry H. S. Soejarto, Djaja Doel Molecules Review The International Cooperative Biodiversity Groups (ICBG) Program based at the University of Illinois at Chicago (UIC) is a program aimed to address the interdependent issues of inventory and conservation of biodiversity, drug discovery and sustained economic growth in both developing and developed countries. It is an interdisciplinary program involving the extensive synergies and collaborative efforts of botanists, chemists and biologists in the countries of Vietnam, Laos and the USA. The UIC-ICBG drug discovery efforts over the past 18 years have resulted in the collection of a cumulative total of more than 5500 plant samples (representing more than 2000 species), that were evaluated for their potential biological effects against cancer, HIV, bird flu, tuberculosis and malaria. The bioassay-guided fractionation and separation of the bioactive plant leads resulted in the isolation of approximately 300 compounds of varying degrees of structural complexity and/or biological activity. The present paper summarizes the significant drug discovery achievements made by the UIC-ICBG team of multidisciplinary collaborators in the project over the period of 1998–2012 and the projects carried on in the subsequent years by involving the researchers in Hong Kong. MDPI 2016-10-31 /pmc/articles/PMC6273581/ /pubmed/27809237 http://dx.doi.org/10.3390/molecules21111448 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zhang, Hong-Jie
Li, Wan-Fei
Fong, Harry H. S.
Soejarto, Djaja Doel
Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998
title Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998
title_full Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998
title_fullStr Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998
title_full_unstemmed Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998
title_short Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998
title_sort discovery of bioactive compounds by the uic-icbg drug discovery program in the 18 years since 1998
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273581/
https://www.ncbi.nlm.nih.gov/pubmed/27809237
http://dx.doi.org/10.3390/molecules21111448
work_keys_str_mv AT zhanghongjie discoveryofbioactivecompoundsbytheuicicbgdrugdiscoveryprograminthe18yearssince1998
AT liwanfei discoveryofbioactivecompoundsbytheuicicbgdrugdiscoveryprograminthe18yearssince1998
AT fongharryhs discoveryofbioactivecompoundsbytheuicicbgdrugdiscoveryprograminthe18yearssince1998
AT soejartodjajadoel discoveryofbioactivecompoundsbytheuicicbgdrugdiscoveryprograminthe18yearssince1998